Published in J Exp Med on March 06, 2000
Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (2010) 5.10
Autoimmune T cell responses in the central nervous system. Nat Rev Immunol (2009) 4.73
Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor. Nat Immunol (2005) 3.05
Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J Exp Med (2004) 2.94
A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J Exp Med (2001) 2.81
Gene dosage--limiting role of Aire in thymic expression, clonal deletion, and organ-specific autoimmunity. J Exp Med (2004) 2.43
Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (2004) 2.34
Theiler's virus infection: a model for multiple sclerosis. Clin Microbiol Rev (2004) 1.92
Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for the myelin proteolipid protein-specific T cell receptor. Proc Natl Acad Sci U S A (2000) 1.80
Influence of microbial environment on autoimmunity. Nat Immunol (2009) 1.59
Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice. J Clin Invest (2003) 1.59
Foxp3+ CD25+ regulatory T cells specific for a neo-self-antigen develop at the double-positive thymic stage. Proc Natl Acad Sci U S A (2006) 1.47
An immunologically privileged retinal antigen elicits tolerance: major role for central selection mechanisms. J Exp Med (2003) 1.44
Self-reactive human CD4 T cell clones form unusual immunological synapses. J Exp Med (2012) 1.38
Anti-peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin self-peptides B:9-23 and B:13-23. J Clin Invest (2002) 1.26
On the role of dendritic cells in peripheral T cell tolerance and modulation of autoimmunity. J Exp Med (2002) 1.20
Cytokine switch and bystander suppression of autoimmune responses to multiple antigens in experimental autoimmune encephalomyelitis by a single recombinant T-cell receptor ligand. J Neurosci (2009) 1.18
Current status of the immunomodulation and immunomediated therapeutic strategies for multiple sclerosis. Clin Dev Immunol (2011) 1.18
The majority of infiltrating CD8+ T cells in the central nervous system of susceptible SJL/J mice infected with Theiler's virus are virus specific and fully functional. J Virol (2002) 1.16
Coupling of peripheral tolerance to endogenous interleukin 10 promotes effective modulation of myelin-activated T cells and ameliorates experimental allergic encephalomyelitis. J Exp Med (2000) 1.14
Retracted Multiple sclerosis: the role of cytokines in pathogenesis and in therapies. Int J Mol Sci (2012) 1.11
Mobilizing the low-avidity T cell repertoire to kill tumors. Semin Cancer Biol (2007) 1.08
Immune tolerance in multiple sclerosis. Immunol Rev (2011) 1.03
Aire controls gene expression in the thymic epithelium with ordered stochasticity. Nat Immunol (2015) 0.99
Intrinsic and induced regulation of the age-associated onset of spontaneous experimental autoimmune encephalomyelitis. J Immunol (2008) 0.98
Unusual features of self-peptide/MHC binding by autoimmune T cell receptors. Immunity (2005) 0.97
Thymic expression of peripheral tissue antigens in humans: a remarkable variability among individuals. Int Immunol (2005) 0.97
Expression of self-antigen in the thymus: a little goes a long way. J Exp Med (2003) 0.96
Reduced self-reactivity of an autoreactive T cell after activation with cross-reactive non-self-ligand. J Exp Med (2002) 0.94
Autoimmune and autoinflammatory mechanisms in uveitis. Semin Immunopathol (2014) 0.91
Peptide-based immunotherapy of autoimmunity: a path of puzzles, paradoxes and possibilities. Immunology (2001) 0.90
Central and peripheral autoantigen presentation in immune tolerance. Immunology (2004) 0.90
Manipulating antigenic ligand strength to selectively target myelin-reactive CD4+ T cells in EAE. J Neuroimmune Pharmacol (2009) 0.89
T-cell avidity and tuning: the flexible connection between tolerance and autoimmunity. Int Rev Immunol (2006) 0.88
Fetal exposure to high-avidity TCR ligand enhances expansion of peripheral T regulatory cells. J Immunol (2008) 0.85
Anticapsid immunity level, not viral persistence level, correlates with the progression of Theiler's virus-induced demyelinating disease in viral P1-transgenic mice. J Virol (2008) 0.85
Levees of immunological tolerance. Nat Immunol (2009) 0.85
Fundamental differences in the dynamics of CNS lesion development and composition in MP4- and MOG peptide 35-55-induced experimental autoimmune encephalomyelitis. Clin Immunol (2008) 0.84
SJL mice infected with Acanthamoeba castellanii develop central nervous system autoimmunity through the generation of cross-reactive T cells for myelin antigens. PLoS One (2014) 0.84
Modes of Antigen Presentation by Lymph Node Stromal Cells and Their Immunological Implications. Front Immunol (2015) 0.83
Tolerating the nervous system: a delicate balance. J Exp Med (2000) 0.81
Detection of thyroglobulin mRNA as truncated isoform(s) in mouse thymus. Immunology (2005) 0.81
Autoregulatory CD8 T cells depend on cognate antigen recognition and CD4/CD8 myelin determinants. Neurol Neuroimmunol Neuroinflamm (2015) 0.81
Ovarian autoimmune disease: clinical concepts and animal models. Cell Mol Immunol (2014) 0.80
CD24 on thymic APCs regulates negative selection of myelin antigen-specific T lymphocytes. Eur J Immunol (2012) 0.79
A simple immune system simulation reveals optimal movement and cell density parameters for successful target clearance. Immunology (2007) 0.78
Identification of an Epitope from Adenine Nucleotide Translocator 1 That Induces Inflammation in Heart in A/J Mice. Am J Pathol (2016) 0.77
Primary biliary cirrhosis: seeking the silent partner of autoimmunity. Gut (2002) 0.77
Ctla-4 modulates the differentiation of inducible Foxp3+ Treg cells but IL-10 mediates their function in experimental autoimmune encephalomyelitis. PLoS One (2014) 0.77
Mapping of the immunodominant T cell epitopes of the protein topoisomerase I. Ann Rheum Dis (2004) 0.76
Thymic gene transfer of myelin oligodendrocyte glycoprotein ameliorates the onset but not the progression of autoimmune demyelination. Mol Ther (2012) 0.76
Extensive RNA editing and splicing increase immune self-representation diversity in medullary thymic epithelial cells. Genome Biol (2016) 0.76
Subdominant H60 antigen-specific CD8 T-cell response precedes dominant H4 antigen-specific response during the initial phase of allogenic skin graft rejection. Exp Mol Med (2015) 0.76
Recognition of a high affinity MHC class I-restricted epitope of myelin oligodendrocyte glycoprotein by CD8⁺ T cells derived from autoantigen-deficient mice. Front Immunol (2011) 0.76
Selection of Thymocytes Expressing Transgenic TCR Specific for a Minor Histocompatibility Antigen, H60. Immune Netw (2015) 0.75
Immunotherapeutic potential of the immunodominant T-cell epitope of lipocalin allergen Bos d 2 and its analogues. Immunology (2007) 0.75
Shaping of Peripheral T Cell Responses by Lymphatic Endothelial Cells. Front Immunol (2017) 0.75
Autoreactive helper T cells alleviate the need for intrinsic TLR signaling in autoreactive B cell activation. JCI Insight (2017) 0.75
The immunomodulator AS101 suppresses production of inflammatory cytokines and ameliorates the pathogenesis of experimental autoimmune encephalomyelitis. J Neuroimmunol (2014) 0.75
The origin and regulation of autopathogenic T cells. J Clin Immunol (2001) 0.75
Biologically relevant conformational features of linear and cyclic proteolipid protein (PLP) peptide analogues obtained by high-resolution nuclear magnetic resonance and molecular dynamics. J Comput Aided Mol Des (2017) 0.75
The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity (1999) 6.10
Low-affinity ligands for the TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts. Immunity (1999) 4.61
Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell (1993) 4.59
Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science (1998) 3.58
Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J Immunol (1989) 2.70
Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med (1995) 2.62
Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol (1991) 2.46
Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med (1994) 2.45
Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol (1994) 2.03
Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein. Immunity (1998) 1.97
Assembly of CNS myelin in the absence of proteolipid protein. Neuron (1997) 1.93
Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein. J Immunol (1996) 1.70
Endogenous myelin basic protein inactivates the high avidity T cell repertoire. J Exp Med (1998) 1.70
Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin. Proc Natl Acad Sci U S A (1987) 1.58
Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein. J Neuroimmunol (1988) 1.50
Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon gamma by T cells. Proc Natl Acad Sci U S A (1995) 1.49
Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. J Neuroimmunol (1992) 1.41
Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways. Brain Pathol (1996) 1.36
Autoreactivity of T cells from nonobese diabetic mice: an I-Ag7-dependent reaction. Proc Natl Acad Sci U S A (1998) 1.34
The human myelin basic protein gene is included within a 179-kilobase transcription unit: expression in the immune and central nervous systems. Proc Natl Acad Sci U S A (1993) 1.27
Genetic analysis of susceptibility to experimental autoimmune encephalomyelitis in a cross between SJL/J and B10.S mice. J Immunol (1996) 1.23
Identification of an embryonic isoform of myelin basic protein that is expressed widely in the mouse embryo. Proc Natl Acad Sci U S A (1993) 1.19
Evolution of the T-cell repertoire during the course of experimental immune-mediated demyelinating diseases. Immunol Rev (1995) 1.15
Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis. J Immunol (1991) 1.11
Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response. J Exp Med (1998) 1.11
Traffic of hematogenous cells through the central nervous system. Curr Top Microbiol Immunol (1995) 1.11
Myelin protein expression in lymphoid tissues: implications for peripheral tolerance. Immunol Rev (1998) 1.11
Presentation of a T cell receptor antagonist peptide by immunoglobulins ablates activation of T cells by a synthetic peptide or proteins requiring endocytic processing. J Exp Med (1997) 1.07
Thymic expression of myelin basic protein (MBP). Activation of MBP-specific T cells by thymic cells in the absence of exogenous MBP. J Immunol (1996) 1.02
The genetics and epidemiology of diabetes in NOD mice. Immunol Today (1990) 0.96
DM20 mRNA splice product of the myelin proteolipid protein gene is expressed in the murine heart. J Neurosci Res (1992) 0.90
T-cell responses to myelin basic protein in normal and MBP-deficient mice. J Neuroimmunol (1998) 0.89
Myelin protein expression is increased in lymph nodes of mice with relapsing experimental autoimmune encephalomyelitis. J Immunol (1997) 0.88
Specific immunoregulation of the induction and effector stages of relapsing EAE via neuroantigen-specific tolerance induction. Ann N Y Acad Sci (1991) 0.88
Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread. Eur J Immunol (1997) 0.88
Oligodendrocyte progenitors in the embryonic spinal cord express DM-20. Neuropathol Appl Neurobiol (1996) 0.87
Expression of the myelin proteolipid protein gene in the human fetal thymus. J Neuroimmunol (1996) 0.82
Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science (1994) 8.69
Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1. J Virol (1989) 4.07
Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat Immunol (2001) 4.05
Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature (1995) 3.46
IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol (1998) 2.93
CD226 Gly307Ser association with multiple autoimmune diseases. Genes Immun (2008) 2.76
Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells. Am J Transplant (2007) 2.61
Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells. J Immunol (2000) 2.16
An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity (1995) 2.14
Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc Natl Acad Sci U S A (1996) 2.06
CD28/B7 costimulation: a review. Crit Rev Immunol (1998) 1.87
Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for the myelin proteolipid protein-specific T cell receptor. Proc Natl Acad Sci U S A (2000) 1.80
Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1. J Virol (1993) 1.70
Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein. J Immunol (1996) 1.70
Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand J Immunol (2010) 1.70
Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis. J Exp Med (1999) 1.69
Manipulation of the Th1/Th2 balance in autoimmune disease. Curr Opin Immunol (1996) 1.52
Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J Immunol (1997) 1.49
B7-2 (CD86) is essential for the development of IL-4-producing T cells. Int Immunol (1996) 1.43
QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing Il2. Nat Genet (1999) 1.39
Mapping autoimmunity genes. Curr Opin Immunol (1999) 1.36
Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein (residues 178-191) for SJL mice. J Immunol (1992) 1.36
A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens. Proc Natl Acad Sci U S A (1997) 1.33
Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis. J Clin Invest (2001) 1.32
Genetic analysis of susceptibility to experimental autoimmune encephalomyelitis in a cross between SJL/J and B10.S mice. J Immunol (1996) 1.23
Binding site for chitin oligosaccharides in the soybean plasma membrane. Plant Physiol (2001) 1.19
IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis. J Immunol (2000) 1.17
T cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis. Eur J Immunol (1994) 1.16
Coupling of peripheral tolerance to endogenous interleukin 10 promotes effective modulation of myelin-activated T cells and ameliorates experimental allergic encephalomyelitis. J Exp Med (2000) 1.14
Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis. Clin Exp Immunol (2009) 1.09
T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. J Immunol (1995) 1.07
Monoclonal antibodies against oncofetal mucin M1 antigens associated with precancerous colonic mucosae. Cancer Res (1986) 1.07
Presentation of a T cell receptor antagonist peptide by immunoglobulins ablates activation of T cells by a synthetic peptide or proteins requiring endocytic processing. J Exp Med (1997) 1.07
A monoclonal antibody raised to lipomodulin recognizes T suppressor factors in two independent hapten-specific suppressor networks. J Immunol (1989) 1.07
Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes. Diabetologia (2011) 1.06
Autopathogenic T helper cell type 1 (Th1) and protective Th2 clones differ in their recognition of the autoantigenic peptide of myelin proteolipid protein. J Exp Med (1997) 1.06
TCR usage in human and experimental demyelinating disease. Immunol Today (1996) 1.05
Iodine excretion in regions of Ukraine affected by the Chornobyl Accident: experience of the Ukrainian-American cohort study of thyroid cancer and other thyroid diseases. Thyroid (2005) 1.03
Reciprocal expression of co-stimulatory molecules, B7-1 and B7-2, on murine T cells following activation. Eur J Immunol (1995) 1.02
B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors. J Immunol (1997) 1.02
Suppressor T cells: some answers but more questions. Immunol Today (1992) 1.01
The immunopathology of acute experimental allergic encephalomyelitis induced with myelin proteolipid protein. T cell receptors in inflammatory lesions. J Immunol (1992) 0.98
Unaltered thyroid function in mice responding to a highly immunogenic thyrotropin receptor: implications for the establishment of a mouse model for Graves' disease. Clin Exp Immunol (1995) 0.97
Mapping and identification of autoimmunity genes. Curr Opin Immunol (2000) 0.97
Minireview: autoimmune responses to myelin proteolipid protein. Neurochem Res (1994) 0.96
Expansion by self antigen is necessary for the induction of experimental autoimmune encephalomyelitis by T cells primed with a cross-reactive environmental antigen. J Immunol (1998) 0.95
Induction of a cross-reactive idiotype dextran-positive antibody response in two IgH-Cb mouse strains treated with anti-J558 cross-reactive idiotype antibodies. J Exp Med (1983) 0.95
Efficient loading of identical viral peptide onto class II molecules by antigenized immunoglobulin and influenza virus. J Exp Med (1993) 0.95
Expression of functional alpha beta T cell receptor gene rearrangements in suppressor T cell hybridomas correlates with antigen binding, but not with suppressor cell function. J Immunol (1990) 0.93
Intercellular adhesion molecule 1 is critical for activation of CD28-deficient T cells. J Immunol (2000) 0.93
B7.2 (CD86) but not B7.1 (CD80) costimulation is required for the induction of low dose oral tolerance. J Immunol (1999) 0.92
Tuning T cell activation threshold and effector function with cross-reactive peptide ligands. Int Immunol (2000) 0.92
Characterization of endogenous Chinese hamster ovary cell surface molecules that mediate T cell costimulation. Cell Immunol (2001) 0.91
TIM-1 signaling is required for maintenance and induction of regulatory B cells. Am J Transplant (2015) 0.91
Expression and characterization of TCA3: a murine inflammatory protein. J Immunol (1990) 0.90
Engineering of doubly antigenized immunoglobulins expressing T and B viral epitopes. Immunotechnology (1996) 0.90
Neonatal immunity develops in a transgenic TCR transfer model and reveals a requirement for elevated cell input to achieve organ-specific responses. J Immunol (2001) 0.89
Multi-modal antigen specific therapy for autoimmunity. Int Rev Immunol (2001) 0.88
Cellular requirements for the suppression of leucocyte adherence inhibition reactions by serum factors from tumour-bearing mice. Immunology (1986) 0.87
Expression of a hypoglycosylated form of CD86 (B7-2) on human T cells with altered binding properties to CD28 and CTLA-4. J Immunol (1997) 0.87
Structurally derived mutations define congenital heart block-related epitopes within the 200-239 amino acid stretch of the Ro52 protein. Scand J Immunol (2005) 0.87
Identification of genetic loci associated with paralysis, inflammation and weight loss in mouse experimental autoimmune encephalomyelitis. Int Immunol (2001) 0.85
Neonatal exposure to antigen primes the immune system to develop responses in various lymphoid organs and promotes bystander regulation of diverse T cell specificities. J Immunol (2001) 0.85
Heteroclitic proliferative responses and changes in cytokine profile induced by altered peptides: implications for autoimmunity. Proc Natl Acad Sci U S A (1998) 0.85
Successful tumour immunotherapy: possible role of antibodies to anti-inflammatory factors produced by neoplasms. Clin Exp Immunol (1985) 0.84
Changes in the strength of co-stimulation through the B7/CD28 pathway alter functional T cell responses to altered peptide ligands. Int Immunol (1999) 0.84
The thyrotrophin hormone receptor of Graves' disease: overexpression of the extracellular domain in insect cells using recombinant baculovirus, immunoaffinity purification and analysis of autoantibody binding. J Mol Endocrinol (1993) 0.84
B7-2 expressed on EL4 lymphoma suppresses antitumor immunity by an interleukin 4-dependent mechanism. J Exp Med (1999) 0.84
A sensitive method to detect defined peptide among those eluted from murine MHC class II molecules. J Immunol Methods (1993) 0.84
Analysis of human T-cell receptor V beta gene usage following immunization to tetanus toxoid in vivo. Immunology (1993) 0.83
The LY-1 gene expression in murine hybridomas producing autoantibodies. Autoimmunity (1990) 0.83
Differential control of neonatal tolerance by antigen dose versus extended exposure and adjuvant. Cell Immunol (2000) 0.82
Inheritance of susceptibility to experimental autoimmune encephalomyelitis. J Neurosci Res (1996) 0.82
Autoantibodies, LY-1, and immunoglobulin V gene expression in hybridomas obtained from young and from old New Zealand black mice. Arthritis Rheum (1990) 0.82
T cell recognition of self and altered self antigens. Crit Rev Immunol (1997) 0.81
Genetics of experimental autoimmune encephalomyelitis. Curr Dir Autoimmun (1999) 0.81
TCR agonist and antagonist exert in vivo cross-regulation when presented on Igs. J Immunol (1998) 0.81
In vivo priming effect during various stages of ontogeny of an influenza A virus nucleoprotein peptide. Eur J Immunol (1993) 0.81
Monoclonal antiidiotypic antibodies related to a murine oncofetal bladder tumor antigen induce specific cell-mediated tumor immunity. Proc Natl Acad Sci U S A (1985) 0.81
The role of cytokines in experimental autoimmune encephalomyelitis. Arch Immunol Ther Exp (Warsz) (2000) 0.81
Ly1 and V-gene expression among hybridomas secreting natural autoantibody. J Autoimmun (1990) 0.80
A single amino acid mutation in CDR3 of the 3-14-9 L chain abolished expression of the IDA 10-defined idiotope and antigen binding. J Immunol (1992) 0.80
Horn cancer in an intact bull. Vet Rec (1980) 0.79
T cell receptor alpha-chain defines the antigen specificity of antigen-specific suppressor factor but does not impart genetic restriction. J Immunol (1995) 0.79
'Lupus-prone' mice are susceptible to organ-specific autoimmune disease, experimental allergic encephalomyelitis. Pathobiology (1994) 0.78
Neonatal tolerant immunity for vaccination against autoimmunity. Int Rev Immunol (2000) 0.78
A monoclonal antibody raised to tumor-specific T cell-derived suppressor factors also recognizes T suppressor inducer factors of the 4-hydroxy-3-nitrophenyl acetyl hapten suppressor network. J Immunol (1987) 0.78
The role of tunable activation thresholds in the dynamics of autoimmunity. J Theor Biol (2012) 0.78
Characterization of the phenotype and function of CD8(+), alpha / beta(+) NKT cells from tumor-bearing mice that show a natural killer cell activity and lyse multiple tumor targets. Eur J Immunol (2001) 0.78